The effect of anticoagulant drugs on cancer

被引:32
作者
Falanga, A [1 ]
机构
[1] Osped Riuniti Bergamo, Dept Hematol Oncol, Div Hematol, I-24128 Bergamo, Italy
关键词
D O I
10.1111/j.1538-7836.2004.00868.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1263 / 1265
页数:3
相关论文
共 18 条
[1]   A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer [J].
Altinbas, M ;
Coskun, HS ;
Er, O ;
Ozkan, M ;
Eser, B ;
Unal, A ;
Cetin, M ;
Soyuer, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1266-1271
[2]   WARFARIN INHIBITS BOTH PROCOAGULANT ACTIVITY AND METASTATIC CAPACITY OF LEWIS LUNG-CARCINOMA CELLS - ROLE OF VITAMIN-K DEFICIENCY [J].
COLUCCI, M ;
DELAINI, F ;
VITTI, GDB ;
LOCATI, D ;
POGGI, A ;
SEMERARO, N ;
DONATI, MB .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (11) :1689-1691
[3]  
Falanga Anna, 2003, Clin Adv Hematol Oncol, V1, P673
[4]   Do heparins do more than just treat thrombosis?: The influence of heparins on cancer spread [J].
Hettiarachchi, RJK ;
Smorenburg, SM ;
Ginsberg, J ;
Levine, M ;
Prins, MH ;
Büller, HR .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) :947-952
[5]   Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS) [J].
Kakkar, AK ;
Levine, MN ;
Kadziola, Z ;
Lemoine, NR ;
Low, V ;
Patel, HK ;
Rustin, G ;
Thomas, M ;
Quigley, M ;
Williamson, RCN .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1944-1948
[6]  
KLERK CPW, IN PRESS J CLIN ONCO
[7]  
LEBEAU B, 1994, CANCER, V74, P38, DOI 10.1002/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO
[8]  
2-E
[9]  
Lee AY, 2003, P AN M AM SOC CLIN, V22, P211
[10]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153